AI & Machine Learning Startups

POC Pharma offers a data analytics solution that combines its proprietary pharmaceutical data with clients' existing datasets to guide customer segmentation, sales targeting, and marketing decisions. The tools help pharmaceutical commercial teams assess promotion ROI, identify growth opportunities, and allocate resources across customer segments and channels.

1 investor

Pharmesol builds a network of AI agents that automate manual, fragmented processes across healthcare systems and workflows, aiming to make medications safer and easier for patients and clinicians. The platform handles routine operational tasks and turns interactions into insights for care teams.

1 investor

Phaselaw is a software platform that automates the processing of public records requests, freedom of information requests, and data subject access requests for government agencies and public sector organizations. The platform uses AI to identify sensitive data, manage redactions, and generate audit trails to ensure compliance with public records laws and regulations.

1 investor

Phaselaw is document review and redaction software that ingests large document sets, deduplicates and organizes files, and produces review-ready PDFs with search and redaction tools. It targets legal professionals handling high-volume document processing.

1 investor

Phase Shift develops custom alloys using an AI and multi-scale simulation platform that designs, optimizes, and evaluates new material chemistries. It serves engineering industries such as aerospace, automotive, energy infrastructure, and medical devices with bespoke materials tailored to specific property requirements.

1 investor

Phastar is a biometrics and data science contract research organization serving pharmaceutical, biotech, and medical device companies. The firm uses data analytics, AI, and statistical expertise to accelerate clinical trial data management and regulatory approvals.

1 investor

PhazeRo is a consulting firm specializing in process optimization, data analysis, and custom artificial intelligence solutions for businesses across various industries. The company helps clients make data-driven decisions and stay competitive by developing predictive models and leveraging advanced technologies.

1 investor

PHC Global builds AI-driven systems that fuse distributed biological data streams (wastewater, clinical, syndromic, environmental) with contextual intelligence to detect anomalies and produce decision-ready biological threat intelligence. Its commercial software platform serves defense, public safety, and U.S. Fortune 500 enterprises for biosurveillance and operational risk protection.

1 investor

phData builds intelligent systems for enterprises, combining trusted data foundations, scalable infrastructure, and operational systems to move AI and machine learning projects from experimentation into production. It offers services such as a fixed-fee four-week sprint where forward-deployed engineers develop prototypes and deployable MVPs against a client's real data and business problems.

1 investor

Phelix AI is an AI automation platform for healthcare providers and clinics that handles administrative workflows such as fax triaging, phone answering, scheduling, referrals, prior authorization, intake, charting, and follow-ups. It offers document- and note-processing APIs that convert unstructured healthcare PDFs into structured data and integrate with EHR, RIS, and HIS systems, available in Canada and US regions.

1 investor

Phenomics Health builds a medication-response intelligence platform that combines high-complexity clinical laboratory testing, pharmacogenomics, pharmacometabolomics, and AI-enabled analytics to support precision prescribing and medication decisions. It serves clinicians, payors, providers, and life-sciences partners in the precision-medicine space.

1 investor

Phenomix Sciences applies data analytics and patient data to enable precision obesity medicine, aiming to guide treatment decisions for anti-obesity medications such as GLP-1s and reduce care costs. Its platform-based approach targets the healthcare market for obesity treatment.

1 investor

Phenyx Health builds decision-making software for complex, multi-appointment and resource-intensive healthcare processes, using descriptive, predictive, and prescriptive analytics to standardize, automate, and optimize managerial decisions. Its tools, offered for cloud-based or on-premise deployment, target patients and clinical staff by integrating information across process silos.

1 investor

Phi Optics develops quantitative phase imaging (QPI) technology that upgrades existing microscopes to enable non-invasive, real-time 3D imaging of live cells, tissues, organoids, and small organisms without labels or specimen damage. The technology serves research institutions and clinical laboratories in life sciences and diagnostics.

1 investor

Agno provides AgentOS, a self-hosted platform and framework for building, running, and managing AI agents, teams of agents, and workflows, with APIs for sessions, memory, knowledge, and tracing plus a control-plane UI. It targets engineering teams at companies building agents, running entirely within the customer's own cloud (AWS, GCP, Railway) for data privacy.

1 investor

Philolabs builds a verification layer for visual AI, focused on alignment and safety infrastructure for video understanding and generation models. It serves frontier AI labs training multimodal visual intelligence systems, operating in the AI alignment and machine learning space.

1 investor

Philon develops open-source robots designed to handle hazardous, repetitive, and unengaging work across general applications.

1 investor

Philosopher King builds a narrative-driven open world gaming platform that uses AI agents to generate adaptive, player-driven storytelling. It targets players and game experiences where choices shape unique narratives in expansive virtual environments.

1 investor

Philter offers a management operating system paired with an AI agency service that redesigns a company's operating model, builds a live workspace turning meetings and notes into decisions and tasks, and deploys agentic workflows with human review gates. It serves founders, executives, chiefs of staff, and operations leaders scaling AI-native organizations where AI agents and people work together.

1 investor

Phinomics is a cancer drug discovery platform that captures extrachromosomal circular DNA (the "Circulome") at high resolution from matched tumor and normal patient samples, integrating it with DNA, RNA, epigenetics, and proteomics into a multi-omic knowledge graph. It applies explainable AI to this data to identify novel therapeutic targets, resistance mechanisms, and patient stratification biomarkers for oncology therapeutics development.

1 investor

Phi is a 5-week live cohort program teaching UX and product designers how to design AI-native interfaces using its "6 Trust Mechanics" framework, covering AI-integrated UX workflows, case studies, and portfolio preparation. It targets mid-level designers with 3–7 years of experience in India, including product designers at SaaS companies and freelancers.

1 investor

Phluence develops an AI-powered multiagent platform that automates and optimizes patient support workflows for pharmaceutical companies, including enrollment, case management, benefit verification, and market access functions. The platform serves pharma manufacturers managing complex patient services operations around reimbursement, clinical education, and financial assistance.

1 investor

PHOENIQS is a Swiss provider of sovereign cloud infrastructure and AI services, offering AI-ready hosting, access to open-source models, and a platform to deploy governed AI applications and agents within Swiss jurisdiction. It serves organizations seeking data control, compliance, and data sovereignty.

1 investor

PhoenixAI is a real-time analytical database that runs sub-second SQL across streaming data and Apache Iceberg lakehouses to support AI agent queries and customer-facing analytics at high concurrency. It is fully managed within the customer's own cloud (BYOC on AWS, Azure, or GCP) and connects through standard SQL, serving data and analytics teams handling large-scale workloads.

1 investor